Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer

Share this content:
Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer
 
Sponspors and Collaborators
H. Lee Moffitt Cancer Center and Research Institute
Celgene Corporation
 
Contact
Mayer Fishman, MD, PH.D
813-745-8343
 
Investigator
Mayer Fishman,MD,PH.D
H. Lee Moffitt Cancer Center and Research Institute
 
ClinicalTrials.gov Identifier
NCT01373294

 

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.